Lutathera (lutetium Lu 177 dotatate)

News alerts, weekly reports and conference planners

Company:

Novartis

Drug class:

Beta radiation emitter, SSTR2 modulator

Related drugs:

SSTR positive	Neuroendocrine Tumor	SSTR positive	Neuroendocrine Tumor	lutetium Lu 177 dotatate Sensitive: A1 - Approval lutetium Lu 177 dotatate Sensitive : A1	lutetium Lu 177 dotatate Sensitive: A1 - Approval lutetium Lu 177 dotatate Sensitive : A1
SSTR2 underexpression	Neuroendocrine Tumor	SSTR2 underexpression	Neuroendocrine Tumor	lutetium Lu 177 dotatate Sensitive: D – Preclinical lutetium Lu 177 dotatate Sensitive : D	lutetium Lu 177 dotatate Sensitive: D – Preclinical lutetium Lu 177 dotatate Sensitive : D

Associations
(2)